07:00 , Sep 14, 2009 |  BC Week In Review  |  Clinical News

Biovista preclinical data

In an experimental allergic encephalomyelitis (EAE) murine model of MS, BVA-201 significantly reduced the severity of EAE from baseline, the magnitude of which was comparable to dexamethasone. BVA-201 also protected neural axons and myelin from...